NYSEAMERICAN:ISR Isoray Stock Forecast, Price & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Isoray, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. $0.28 +0.01 (+2.96%) (As of 06/29/2022 01:09 PM ET) Add Compare Share Today's Range$0.28▼$0.2950-Day Range N/A52-Week Range$0.25▼$0.82Volume4,200 shsAverage Volume385,812 shsMarket Capitalization$39.49 millionP/E RatioN/ADividend YieldN/APrice Target$1.25 ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive ISR Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Isoray and its competitors with MarketBeat's FREE daily newsletter. Email Address ISR Stock Forecast (MarketRank)Overall MarketRank™2.24 out of 5 starsAnalyst Opinion: 3.5Community Rank: 4.8Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 1.3 5 -4 -3 -2 -1 - 3.5 Analyst's Opinion Consensus RatingIsoray has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $1.25, Isoray has a forecasted upside of 340.9% from its current price of $0.28.Amount of Analyst CoverageIsoray has received no research coverage in the past 90 days. Previous Next 4.8 Community Rank Outperform VotesIsoray has received 185 “outperform” votes. (Add your “outperform” vote.)Underperform VotesIsoray has received 75 “underperform” votes. (Add your “underperform” vote.)Community SentimentIsoray has received 71.15% “outperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Isoray and other stocks. Vote “Outperform” if you believe ISR will outperform the S&P 500 over the long term. Vote “Underperform” if you believe ISR will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldIsoray does not currently pay a dividend.Dividend GrowthIsoray does not have a long track record of dividend growth. Previous Next 1.7 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Isoray insiders have bought more of their company's stock than they have sold. Specifically, they have bought $27,631.00 in company stock and sold $0.00 in company stock.Percentage Held by InsidersOnly 2.42% of the stock of Isoray is held by insiders.Percentage Held by InstitutionsOnly 11.16% of the stock of Isoray is held by institutions. Previous Next 1.3 Earnings and Valuation Earnings GrowthEarnings for Isoray are expected to grow in the coming year, from ($0.04) to ($0.02) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Isoray is -5.67, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Isoray is -5.67, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioIsoray has a P/B Ratio of 0.59. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About Isoray (NYSEAMERICAN:ISR)Isoray, Inc., through its subsidiary, IsoRay Medical, Inc., develops, manufactures, and sells isotope-based medical products and devices for the treatment of cancer and other malignant diseases in the United States and internationally. The company offers CS-1 Cesium-131 brachytherapy seeds for the treatment of prostate, brain, lung, head and neck, gynecological, pelvic/abdominal, and colorectal cancers. It sells its products to facilities or physician practices that utilize various surgical facilities. Isoray, Inc. was founded in 1998 and is based in Richland, Washington.Read More ISR Stock News HeadlinesJune 26, 2022 | americanbankingnews.comIsoray (NYSEAMERICAN:ISR) Shares Pass Above 200-Day Moving Average of $0.00June 21, 2022 | finance.yahoo.comIsoray’s Cesium-131 Featured in Presentations at American Brachytherapy Society’s Annual ConferenceJune 21, 2022 | globenewswire.comIsoray's Cesium-131 Featured in Presentations at American Brachytherapy Society's Annual Conference - GlobeNewswireJune 15, 2022 | globenewswire.comIsoray To Host Lunch Symposium At American Brachytherapy Society's Annual Conference - GlobeNewswireJune 15, 2022 | finance.yahoo.comIsoray To Host Lunch Symposium At American Brachytherapy Society’s Annual ConferenceJune 9, 2022 | globenewswire.comRadiotherapy Market Size Worth USD 9641.89 Million by 2030 at 5.49% CAGR - Report by Market Research Future (MRFR) - GlobeNewswireJune 7, 2022 | americanbankingnews.comIsoray (NYSEAMERICAN:ISR) Shares Cross Above 200 Day Moving Average of $0.00May 17, 2022 | streetinsider.comForm 424B5 Isoray, Inc. - StreetInsider.comMay 10, 2022 | finance.yahoo.comIsoRay (ISR) Reports Q3 Loss, Lags Revenue EstimatesMay 10, 2022 | globenewswire.comIsoray Announces Record Third Quarter Fiscal 2022 Financial Results - GlobeNewswireMay 10, 2022 | finance.yahoo.comIsoray Announces Record Third Quarter Fiscal 2022 Financial ResultsApril 29, 2022 | globenewswire.comIsoray To Announce Third Quarter Fiscal 2022 Financial Results on May 10, 2022 - GlobeNewswireApril 29, 2022 | finance.yahoo.comIsoray To Announce Third Quarter Fiscal 2022 Financial Results on May 10, 2022See More Headlines Industry, Sector and Symbol Stock ExchangeNYSEAMERICAN Industry Surgical & medical instruments Sub-IndustryN/A SectorMedical Current SymbolNYSEAMERICAN:ISR Previous SymbolNYSEMKT:ISR CUSIPN/A CIK728387 Webisoray.com Phone(509) 375-1202Fax509-267-3670Employees61Year FoundedN/ACompany Calendar Last Earnings5/10/2022Today6/29/2022Fiscal Year End6/30/2022Next Earnings (Estimated)9/19/2022Price Target and Rating Average Stock Price Forecast$1.25 High Stock Price Forecast$1.25 Low Stock Price Forecast$1.25 Forecasted Upside/Downside+349.6%Consensus RatingBuy Rating Score (0-4)3 Research Coverage1 Analysts Profitability EPS (Most Recent Fiscal Year)($0.05) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-3.39 million Net Margins-48.05% Pretax Margin-48.05% Return on Equity-9.19% Return on Assets-8.71% Debt Debt-to-Equity RatioN/A Current Ratio36.11 Quick Ratio35.52 Sales & Book Value Annual Sales$10.05 million Price / Sales3.93 Cash FlowN/A Price / Cash FlowN/A Book Value$0.48 per share Price / Book0.58Miscellaneous Outstanding Shares142,040,000Free Float138,481,000Market Cap$39.49 million OptionableNot Optionable Beta0.92 Isoray Frequently Asked Questions Should I buy or sell Isoray stock right now? 1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Isoray in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Isoray stock. View analyst ratings for Isoray or view top-rated stocks. What is Isoray's stock price forecast for 2022? 1 Wall Street research analysts have issued 1-year price targets for Isoray's shares. Their ISR stock forecasts range from $1.25 to $1.25. On average, they anticipate Isoray's stock price to reach $1.25 in the next year. This suggests a possible upside of 349.6% from the stock's current price. View analysts' price targets for Isoray or view top-rated stocks among Wall Street analysts. How has Isoray's stock price performed in 2022? Isoray's stock was trading at $0.38 at the beginning of 2022. Since then, ISR stock has decreased by 26.8% and is now trading at $0.2780. View the best growth stocks for 2022 here. When is Isoray's next earnings date? Isoray is scheduled to release its next quarterly earnings announcement on Monday, September 19th 2022. View our earnings forecast for Isoray. How were Isoray's earnings last quarter? Isoray, Inc. (NYSEAMERICAN:ISR) posted its quarterly earnings data on Tuesday, May, 10th. The healthcare company reported ($0.01) earnings per share (EPS) for the quarter, meeting the consensus estimate of ($0.01). The healthcare company had revenue of $2.91 million for the quarter, compared to analysts' expectations of $3.15 million. Isoray had a negative net margin of 48.05% and a negative trailing twelve-month return on equity of 9.19%. View Isoray's earnings history. Who are Isoray's key executives? Isoray's management team includes the following people: Ms. Lori A. Holmes-Woods, CEO & Director (Age 60, Pay $371.19k)Ms. Jennifer Streeter, COO & VP of HR (Age 52, Pay $266.35k)Mr. William A. Cavanagh III, Chief R&D Officer (Age 56, Pay $253.34k)Mr. Jonathan R. Hunt, CFO & Co-Principal Financial Officer (Age 55)Mr. Mark J. Austin CPA, VP of Fin., Controller, Co-Principal Financial, Principal Accounting Officer & Sec. (Age 35)Ms. Krista Cline, Sr. Director of Operations & Corp. Sec. (Age 40) Who are some of Isoray's key competitors? Some companies that are related to Isoray include Tactile Systems Technology (TCMD), Apollo Endosurgery (APEN), Quipt Home Medical (QIPT), Profound Medical (PROF), Sensus Healthcare (SRTS), NeuroPace (NPCE), AVITA Medical (RCEL), Retractable Technologies (RVP), Retractable Technologies (RVP), Meihua International Medical Technologies (MHUA), Invo Bioscience (IVOB), CVRx (CVRX), DarioHealth (DRIO), LMF Acquisition Opportunities (LMAO) and Repro Med Systems (KRMD). View all of ISR's competitors. What other stocks do shareholders of Isoray own? Based on aggregate information from My MarketBeat watchlists, some companies that other Isoray investors own include Brainstorm Cell Therapeutics (BCLI), OPKO Health (OPK), Bausch Health Companies (BHC), Anavex Life Sciences (AVXL), TherapeuticsMD (TXMD), Catalyst Pharmaceuticals (CPRX), MannKind (MNKD), CTI BioPharma (CTIC), Idera Pharmaceuticals (IDRA) and Palatin Technologies (PTN). What is Isoray's stock symbol? Isoray trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "ISR." Who are Isoray's major shareholders? Isoray's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Bard Associates Inc. (0.47%), State Street Corp (0.39%), Taylor & Morgan Wealth Management LLC (0.39%) and Renaissance Technologies LLC (0.29%). Company insiders that own Isoray stock include Jonathan Robert Hunt, Lori A Woods, Mark John Austin, Michael Krachon, Philip J Vitale and William Cavanagh. View institutional ownership trends for Isoray. Which major investors are selling Isoray stock? ISR stock was sold by a variety of institutional investors in the last quarter, including Renaissance Technologies LLC. View insider buying and selling activity for Isoray or view top insider-selling stocks. Which major investors are buying Isoray stock? ISR stock was purchased by a variety of institutional investors in the last quarter, including Taylor & Morgan Wealth Management LLC, Bard Associates Inc., and State Street Corp. Company insiders that have bought Isoray stock in the last two years include Jonathan Robert Hunt, Lori A Woods, Mark John Austin, Michael Krachon, and Philip J Vitale. View insider buying and selling activity for Isoray or or view top insider-buying stocks. How do I buy shares of Isoray? Shares of ISR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Isoray's stock price today? One share of ISR stock can currently be purchased for approximately $0.28. How much money does Isoray make? Isoray (NYSEAMERICAN:ISR) has a market capitalization of $39.49 million and generates $10.05 million in revenue each year. The healthcare company earns $-3.39 million in net income (profit) each year or ($0.05) on an earnings per share basis. How many employees does Isoray have? Isoray employs 61 workers across the globe. How can I contact Isoray? Isoray's mailing address is 350 Hills St Ste 106, RICHLAND, WA 99354-5511, United States. The official website for Isoray is isoray.com. The healthcare company can be reached via phone at (509) 375-1202, via email at [email protected], or via fax at 509-267-3670. This page (NYSEAMERICAN:ISR) was last updated on 6/29/2022 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply. MarketBeat Resources Premium Research Tools MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools. Discover All Access Market Data and Calendars Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free. View Market Data Investing Education and Resources Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more. Financial Terms Details Here